EP Patent

EP1438048A1 — 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors

Assigned to Boehringer Ingelheim Pharmaceuticals Inc · Expires 2004-07-21 · 22y expired

What this patent protects

Disclosed are compounds of the formula (I) & (II) which are active as anti-inflammatory agents. Also disclosed are methods of using and making such compounds, wherein G, X, A and Q are described herein.

USPTO Abstract

Disclosed are compounds of the formula (I) & (II) which are active as anti-inflammatory agents. Also disclosed are methods of using and making such compounds, wherein G, X, A and Q are described herein.

Drugs covered by this patent

Patent Metadata

Patent number
EP1438048A1
Jurisdiction
EP
Classification
—
Expires
2004-07-21
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.